Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Miami Valley Hospital
746
mi
from
Dayton, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Miami Valley Hospital
746
mi
from
Dayton, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Veteran Affairs Medical Center
746
mi
from
Dayton, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Veteran Affairs Medical Center
746
mi
from
Dayton, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Blanchard Valley Hospital
788
mi
from
Findlay, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Blanchard Valley Hospital
788
mi
from
Findlay, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Atrium Medical Center - Middletown Regional Hospital
738
mi
from
Franklin, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Atrium Medical Center - Middletown Regional Hospital
738
mi
from
Franklin, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Kettering Medical Center
747
mi
from
Kettering, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Kettering Medical Center
747
mi
from
Kettering, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Upper Valley Medical Center
748
mi
from
Troy, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Upper Valley Medical Center
748
mi
from
Troy, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cancer Treatment Center
872
mi
from
Wooster, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cancer Treatment Center
872
mi
from
Wooster, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Greene Memorial Hospital
759
mi
from
Xenia, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Greene Memorial Hospital
759
mi
from
Xenia, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Abington Memorial Hospital
1227
mi
from
Abington, PA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Abington Memorial Hospital
1227
mi
from
Abington, PA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Reading Hospital
1184
mi
from
West Reading, PA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Reading Hospital
1184
mi
from
West Reading, PA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
AnMedical Health Hospital
874
mi
from
Anderson, SC
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
AnMedical Health Hospital
874
mi
from
Anderson, SC
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Greenville Health System Cancer Institute/Eastside
883
mi
from
Greenville, SC
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Greenville Health System Cancer Institute/Eastside
883
mi
from
Greenville, SC
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Spartanburg Medical Center
903
mi
from
Spartanburg, SC
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Spartanburg Medical Center
903
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Rapid City Regional Hospital
520
mi
from
Rapid City, SD
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Rapid City Regional Hospital
520
mi
from
Rapid City, SD
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Wellmont Holston Valley Hospital and Medical Center
843
mi
from
Kingsport, TN
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Wellmont Holston Valley Hospital and Medical Center
843
mi
from
Kingsport, TN
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Thompson Cancer Survival Center
777
mi
from
Knoxville, TN
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Thompson Cancer Survival Center
777
mi
from
Knoxville, TN
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
American Fork Hospital / Huntsman Intermountain Cancer Center
768
mi
from
American Fork, UT
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
American Fork Hospital / Huntsman Intermountain Cancer Center
768
mi
from
American Fork, UT
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Southwest VA Regional Cancer Center
835
mi
from
Norton, VA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Southwest VA Regional Cancer Center
835
mi
from
Norton, VA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University Massey Cancer Center
1113
mi
from
Richmond, VA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University Massey Cancer Center
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
North Star Lodge
1308
mi
from
Yakima, WA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
North Star Lodge
1308
mi
from
Yakima, WA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
690
mi
from
Green Bay, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
690
mi
from
Green Bay, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Hospital Cancer Center at Saint Mary's
689
mi
from
Green Bay, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Saint Mary's
689
mi
from
Green Bay, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Froedtert and the Medical College of Wisconsin
630
mi
from
Milwaukee, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
630
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
ProHealth Oconomowoc Memorial Hospital
613
mi
from
Oconomowoc, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
ProHealth Oconomowoc Memorial Hospital
613
mi
from
Oconomowoc, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
ProHealth Waukesha Memorial Hospital
621
mi
from
Waukesha, WI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
ProHealth Waukesha Memorial Hospital
621
mi
from
Waukesha, WI
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Memorial Health University Medical Center
1026
mi
from
Savannah, GA
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Memorial Health University Medical Center
1026
mi
from
Savannah, GA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Akron General
897
mi
from
Akron, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Akron General
897
mi
from
Akron, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
UH Seidman Cancer Center at Salem Regional Medical Center
844
mi
from
Salem, OH
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
UH Seidman Cancer Center at Salem Regional Medical Center
844
mi
from
Salem, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Ascension Saint John Hospital
841
mi
from
Detroit, MI
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Ascension Saint John Hospital
841
mi
from
Detroit, MI
Click here to add this to my saved trials
HGS-ETR2 to Treat Children With Solid Tumors
A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) With or Without Interferon Gamma in Patients With Refractory Pediatric Solid Tumors
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
HGS-ETR2 to Treat Children With Solid Tumors
A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) With or Without Interferon Gamma in Patients With Refractory Pediatric Solid Tumors
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Phase I Study of Oral Yeast β-Glucan and Intravenous Anti-GD2 Monoclonal Antibody 3F8 Among Patients With Metastatic Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
1289
mi
from
New York, NY
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Phase I Study of Oral Yeast β-Glucan and Intravenous Anti-GD2 Monoclonal Antibody 3F8 Among Patients With Metastatic Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
1289
mi
from
New York, NY
Click here to add this to my saved trials
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer
A Pilot Study of the Effectiveness of Cognitive Training in Preventing Attention Deficits Among Children in Treatment for Cancer
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer
A Pilot Study of the Effectiveness of Cognitive Training in Preventing Attention Deficits Among Children in Treatment for Cancer
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy
A Phase III Prospective Randomized Trial Comparing Radiosurgery With Versus Without Whole Brain Radiotherapy for 1-3 Newly Diagnosed Brain Metastases
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy
A Phase III Prospective Randomized Trial Comparing Radiosurgery With Versus Without Whole Brain Radiotherapy for 1-3 Newly Diagnosed Brain Metastases
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
1289
mi
from
New York, NY
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
1289
mi
from
New York, NY
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Scottsdale
835
mi
from
Scottsdale, AZ
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Scottsdale
835
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cancer Care Associates
1204
mi
from
Fresno, CA
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cancer Care Associates
1204
mi
from
Fresno, CA
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Front Range Cancer Specialists
429
mi
from
Fort Collins, CO
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Front Range Cancer Specialists
429
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
1358
mi
from
Hartford, CT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
1358
mi
from
Hartford, CT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Baptist Cancer Institute - Jacksonville
1058
mi
from
Jacksonville, FL
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Baptist Cancer Institute - Jacksonville
1058
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
1061
mi
from
Jacksonville, FL
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
1061
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Rush-Copley Cancer Care Center
576
mi
from
Aurora, IL
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Rush-Copley Cancer Care Center
576
mi
from
Aurora, IL
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Carle Cancer Center at Carle Foundation Hospital
541
mi
from
Urbana, IL
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Carle Cancer Center at Carle Foundation Hospital
541
mi
from
Urbana, IL
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
CCOP - Carle Cancer Center
541
mi
from
Urbana, IL
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
CCOP - Carle Cancer Center
541
mi
from
Urbana, IL
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
St. Francis Hospital and Health Centers - Beech Grove Campus
646
mi
from
Beech Grove, IN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
St. Francis Hospital and Health Centers - Beech Grove Campus
646
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Reid Hospital & Health Care Services
710
mi
from
Richmond, IN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Reid Hospital & Health Care Services
710
mi
from
Richmond, IN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
McFarland Clinic, PC
370
mi
from
Ames, IA
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
McFarland Clinic, PC
370
mi
from
Ames, IA
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cedar Rapids Oncology Associates
440
mi
from
Cedar Rapids, IA
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cedar Rapids Oncology Associates
440
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Mercy Regional Cancer Center at Mercy Medical Center
440
mi
from
Cedar Rapids, IA
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Mercy Regional Cancer Center at Mercy Medical Center
440
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Medical Oncology and Hematology Associates-West Des Moines
342
mi
from
Clive, IA
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Medical Oncology and Hematology Associates-West Des Moines
342
mi
from
Clive, IA
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Mercy Capitol Hospital
352
mi
from
Des Moines, IA
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Mercy Capitol Hospital
352
mi
from
Des Moines, IA
Click here to add this to my saved trials